Clinical Trial Update: A Study of TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation [Phase 1]

View source ↗

Summary

This is a Phase 1 trial update announcing ongoing recruitment for a study evaluating TSC-100 and TSC-101 in patients with acute myeloid leukemia, acute lymphobl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• TSC-100
• TSC-101

Snippet

Sponsor: TScan Therapeutics, Inc. | Conditions: AML, Myelodysplastic Syndromes | Phase 1 | Status: RECRUITING